EUVIMEDEUVIMED entdecken
Crossref

Abrupt withdrawal of Chlorpromazine and Thioridazine from Schizophrenic In-Patients

W. T. Melnyk, A. G. Worthington, S. G. Laverty

Canadian Psychiatric Association Journal · 1966-10 · 11 (5) · 410-413

DOI: 10.1177/070674376601100507 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Psychiatric Association Journal, online erschienen am 26.04.2017. Verfasst von W. T. Melnyk und 2 weiteren Autor:innen. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study forty patients were randomly assigned to either a Continuation of Thioridazine or Chlorpromazine Medication Group or to a Placebo Medication Group. Withdrawal symptoms were recorded in a large majority of the Placebo Group. Characteristically, these symptoms no longer occurred after the second week of withdrawal. Symptoms which characterized the patient's illness prior to phenothiazine treatment were observed in 50 per cent of the Placebo Group by the end of the six weeks' withdrawal period. None of the Drug Group showed relapse symptoms.

Zitieren

APA

Melnyk, W. T., Worthington, A. G., & Laverty, S. G. (1966). Abrupt withdrawal of Chlorpromazine and Thioridazine from Schizophrenic In-Patients. Canadian Psychiatric Association Journal, 11(5), 410-413. https://doi.org/10.1177/070674376601100507

Vancouver

Melnyk WT, Worthington AG, Laverty SG. Abrupt withdrawal of Chlorpromazine and Thioridazine from Schizophrenic In-Patients. Canadian Psychiatric Association Journal. 1966;11(5):410-413. doi:10.1177/070674376601100507

BibTeX
@article{Melnyk1966,
  author = {Melnyk, W. T. and Worthington, A. G. and Laverty, S. G.},
  title = {Abrupt withdrawal of Chlorpromazine and Thioridazine from Schizophrenic In-Patients},
  journal = {Canadian Psychiatric Association Journal},
  year = {1966},
  volume = {11},
  number = {5},
  pages = {410--413},
  doi = {10.1177/070674376601100507}
}
Kostenlos starten →